ASND icon

Ascendis Pharma
ASND

Overview Fund Activity

188 hedge funds and large institutions have $9.19B invested in Ascendis Pharma in 2024 Q1 according to their latest regulatory filings, with 39 funds opening new positions, 73 increasing their positions, 50 reducing their positions, and 33 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
188
Holders Change
+4
Holders Change %
+2.17%
% of All Funds
2.73%
Holding in Top 10
16
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.23%
New
39
Increased
73
Reduced
50
Closed
33
Calls
$48.3M
Puts
$51.8M
Net Calls
-$3.49M
Net Calls Change
-$9.66M

Top Buyers

1
Franklin Resources
Franklin Resources
California
$300M
2
Millennium Management
Millennium Management
New York
$54.7M
3
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$269M
4
Citadel Advisors
Citadel Advisors
Florida
$69.2M
5
Acadian Asset Management
Acadian Asset Management
Massachusetts
$37.8M

Top Sellers

1
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
$388M
2
Wellington Management Group
Wellington Management Group
Massachusetts
$415M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
$569M
4
TCM
TimesSquare Capital Management
New York
$87M
5
Fidelity Investments
Fidelity Investments
Massachusetts
$747M
Name Holding Trade Value Shares
Change 		Shares
Change %
RCM
1
RA Capital Management
Massachusetts
$1.53B +$151K +1,000 +0%
Artisan Partners
2
Artisan Partners
Wisconsin
$857M -$11.7M -77,293 -1%
Fidelity Investments
3
Fidelity Investments
Massachusetts
$747M -$26.6M -175,908 -3%
Westfield Capital Management
4
Westfield Capital Management
Massachusetts
$616M +$6.74M +44,580 +1%
ACA
5
Avoro Capital Advisors
New York
$600M +$31.9M +211,111 +6%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$569M -$34.4M -227,582 -6%
Wellington Management Group
7
Wellington Management Group
Massachusetts
$415M -$76M -502,421 -15%
T. Rowe Price Investment Management
8
T. Rowe Price Investment Management
Maryland
$388M -$215M -1,420,927 -36%
Capital International Investors
9
Capital International Investors
California
$331M +$1.52M +10,044 +0.5%
Franklin Resources
10
Franklin Resources
California
$300M +$139M +917,064 +86%
T. Rowe Price Associates
11
T. Rowe Price Associates
Maryland
$269M +$50.9M +336,976 +23%
Massachusetts Financial Services
12
Massachusetts Financial Services
Massachusetts
$245M +$14.9M +98,611 +6%
Invesco
13
Invesco
Georgia
$146M +$8.58M +56,752 +6%
SI
14
Sofinnova Investments
California
$114M – – –
Brown Advisory
15
Brown Advisory
Maryland
$103M +$26.9M +178,125 +35%
SCM
16
Spyglass Capital Management
California
$92.8M +$11.2M +74,159 +14%
TCM
17
TimesSquare Capital Management
New York
$87M -$32.8M -217,247 -27%
VPC
18
Vestal Point Capital
New York
$79.4M -$15.1M -100,000 -16%
PBA
19
Paradigm Biocapital Advisors
New York
$76.8M +$23.6M +156,252 +44%
AllianceBernstein
20
AllianceBernstein
Tennessee
$71.6M -$17.4M -115,183 -20%
Citadel Advisors
21
Citadel Advisors
Florida
$69.2M +$43.2M +285,933 +167%
Goldman Sachs
22
Goldman Sachs
New York
$66.1M +$2.15M +14,238 +3%
BlackRock
23
BlackRock
New York
$61.2M +$8.49M +56,147 +16%
Millennium Management
24
Millennium Management
New York
$54.7M +$51.3M +339,669 +1,517%
SEI Investments
25
SEI Investments
Pennsylvania
$52.3M -$2.36M -15,644 -4%
1
2 3 4 5